- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | 2 | Seeking Alpha | ||
| Di | Shionogi & Co. reports Q2 results | 3 | Seeking Alpha | ||
| Di | Japan's Shionogi says Phase 3 study showed COVID pill reduces transmission | 4 | Reuters | ||
| 01.10. | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | 146 | GlobeNewswire (Europe) | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
| 30.07. | Earnings call: Shionogi reports mixed results, optimistic on pipeline progress | 9 | Investing.com | ||
| 14.05. | Shionogi & Co. reports FY results | 7 | Seeking Alpha | ||
| 13.05. | Shionogi's antiviral comes up short in global COVID-19 trial | 4 | FiercePharma | ||
| 13.05. | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | 6 | Reuters | ||
| 10.05. | Shionogi gains rights to Maze's investigational Pompe disease therapy for $150m upfront | 4 | PMLiVE | ||
| 10.05. | Shionogi secures licence for Maze's Pompe disease treatment | 4 | Pharmaceutical Technology | ||
| 10.05. | After FTC stalled Sanofi deal, Shionogi secures Maze's Pompe disease drug for $150M | 9 | FierceBiotech | ||
| 09.05. | Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | 1.024 | PR Newswire | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects... ► Artikel lesen | |
| 22.12.23 | Juniper Biologics: Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore | 752 | PR Newswire | First drug to show both clinical symptomatic efficacy for five typical Omicron-related symptoms and antiviral efficacy
SINGAPORE, Dec. 21, 2023 /PRNewswire/ -- Singapore-headquartered... ► Artikel lesen | |
| 20.12.23 | Pixie Dust Technologies, Inc.: "Bekämpfen von Demenz mit Klangtherapie"- Pixie Dust Technologies, Shionogi und Shionogi Healthcare entwickeln Gamma-Wellen-Klänge zur Verbesserung der alltäglichen kognitiven Fähigkeiten | 724 | Business Wire | Pixie Dust Technologies, Inc., Shionogi Co. und Shionogi Healthcare Co. haben mit "Memory" und "Tomorrow" zwei Hörerlebnisse auf Basis der Gamma-Wellen-Technologie1 veröffentlicht, die Demenzpatienten... ► Artikel lesen | |
| 20.12.23 | Pixie Dust Technologies, Inc.: "Defy Dementia with Sound." Pixie Dust Technologies, Shionogi and Shionogi Healthcare create Gamma Wave Sound to boost everyday cognitive care. | 869 | Business Wire | Pixie Dust Technologies, Inc., Shionogi Co., Ltd, and Shionogi Healthcare Co., Ltd released "Memory" and "Tomorrow", two audio experiences incorporating gamma wave technology1 designed to provide... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 11,300 | 0,00 % | Trulieve Has Spent $141M On Push For Florida Marijuana Amendment | ||
| WEST PHARMACEUTICAL SERVICES | 291,10 | -0,38 % | West Pharmaceutical Services Aktie: Zukunftsplan mit Erfolg | West Pharmaceutical Services, Inc. hat mit seinen jüngsten Quartalszahlen die Erwartungen übertroffen und damit für Aufsehen an der Börse gesorgt. Der Aktienkurs des Medizintechnikunternehmens reagierte... ► Artikel lesen | |
| SHIONOGI | 13,500 | +0,75 % | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | ||
| HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Holdings Corp.: Heritage Cannabis Announces Completion of Sale and Delisting from the CSE and the OTCQX | TORONTO, Aug. 29, 2024 /CNW/ - Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announces, that, in connection with its creditor protection proceedings... ► Artikel lesen | |
| KALA BIO | 6,405 | +2,89 % | KALA BIO: Vorstandsmitglied tritt zurück | ||
| CHARLOTTES WEB | 0,106 | -5,36 % | Charlotte's Web Holdings Aktie: Umsatzrückgang belastet Aktienkurs | ||
| BEXIMCO | 0,344 | 0,00 % | Beximco Pharma. - Notification of Preliminary Results and AGM | ||
| LUYE PHARMA | 0,334 | -1,76 % | LUYE PHARMA (02186): OVERSEAS REGULATORY ANNOUNCEMENT | ||
| GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
| MIRUM PHARMACEUTICALS | 36,200 | -3,21 % | Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Rating of "Buy" by Analysts | ||
| PERCHERON THERAPEUTICS | 0,046 | -3,77 % | PERCHERON THERAPEUTICS LIMITED: Quarterly Activities Report and Appendix 4C | ||
| AYURCANN | 0,020 | +5,41 % | Ayurcann Holdings Corp.: Ayurcann Reports Fiscal Year 2024 Record Sales Of $45,265,235 In Gross Revenue, Featuring Another 100% Year-over-year Increase | Toronto, Ontario, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) ("Ayurcann" or the "Company"), a leading Canadian processing and manufacturing company... ► Artikel lesen | |
| EVEREST MEDICINES | 3,680 | -1,08 % | Everest Medicines Limited: Everest Medicines Announces the Launch of VELSIPITY(R) in the Guangdong-Hong Kong-Macau Greater Bay Area | - Offering a New Option for Moderately to Severely Active Ulcerative Colitis PatientsHONG KONG, Oct 25, 2024 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical... ► Artikel lesen | |
| AVANT BRANDS | 0,600 | 0,00 % | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen | |
| KALBE FARMA | 0,084 | -2,89 % | KLBF strengthens prescription drug business by inaugurating radioisotope factory: PT Kalbe Farma Tbk ... |
SHIONOGI & CO LTD ADR gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 10,300 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.
